Skip to Main Content

Author Details

John Trachtenberg
University of Toronto, University Health Network
1971
250
62
PMIDPaper TitleJournal TitlePublished Year
34324385Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer.Br J Radiol2022
30873696Pfilates and Hypopressives for the Treatment of Urinary Incontinence After Radical Prostatectomy: Results of a Feasibility Randomized Controlled Trial.PM R2020
32154965Associations between self-reported physical activity, quality of life, and emotional well-being in men with prostate cancer on active surveillance.Psychooncology2020
30952966Internet information on focal prostate cancer therapy: help or hindrance?Nat Rev Urol2019
31309377Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer.Cancer Causes Control2019
28613997Psychological distress and lifestyle disruption in low-risk prostate cancer patients: Comparison between active surveillance and radical prostatectomy.J Psychosoc Oncol2018
30607114The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy.Curr Oncol2018
29696431Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.Eur Radiol2018
29381462Next-generation prostate cancer risk calculator for primary care physicians.Can Urol Assoc J2018
27457260Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.J Urol2017
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
28693181Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.Oncol Lett2017
27015944Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy.Urology2016
28096933The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy.Can Urol Assoc J2016
24568896Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.Eur Urol2015
26377550A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol.BMC Urol2015
26715869Enablers and barriers in delivery of a cancer exercise program: the Canadian experience.Curr Oncol2015
26204305Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.AJR Am J Roentgenol2015
26225166Health-related quality of life in robotic versus open radical prostatectomy.Can Urol Assoc J2015
26166964MRI-guided biopsies and minimally invasive therapy for prostate cancer.Indian J Urol2015
25624044Elastic registration of prostate MR images based on estimation of deformation states.Med Image Anal2015
25695793In-bore MRI interventions: current status and future applications.Curr Opin Urol2015
25667108Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.Prostate Cancer Prostatic Dis2015
25481037Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates.J Urol2015
25195664Mechatronic system for in-bore MRI-guided insertion of needles to the prostate: An in vivo needle guidance accuracy study.J Magn Reson Imaging2015
24841929Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy.BJU Int2015
23769825The role of focal therapy in the management of localised prostate cancer: a systematic review.Eur Urol2014
25443907The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.Urology2014
25408811Dynamic contrast enhanced MRI as a predictor of vascular-targeted photodynamic focal ablation therapy outcome in prostate cancer post-failed external beam radiation therapy.Can Urol Assoc J2014
25408810Active surveillance in patients with a PSA >10 ng/mL.Can Urol Assoc J2014
25485004Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic.Can Urol Assoc J2014
25505413The acute effects of exercise on cortical excitation and psychosocial outcomes in men treated for prostate cancer: a randomized controlled trial.Front Aging Neurosci2014
25279276Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.Springerplus2014
25394949Prehabilitation for men undergoing radical prostatectomy: a multi-centre, pilot randomized controlled trial.BMC Surg2014
25101567The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.Br J Cancer2014
24812057Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts.Endocr Relat Cancer2014
24861559A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.Prostate Cancer Prostatic Dis2014
24954793Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.Eur Urol2014
24609438Health-related quality of life following radical prostatectomy: long-term outcomes.Qual Life Res2014
24578745Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?Can Urol Assoc J2014
24637422Prostate cancer: a consensus on trial design for focal therapy.Nat Rev Urol2014
24703897Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.Eur J Cancer2014
24317972The effect of meeting physical activity guidelines for cancer survivors on quality of life following radical prostatectomy for prostate cancer.J Cancer Surviv2014
24311408Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression.Prostate2014
24387531Treatment planning for prostate focal laser ablation in the face of needle placement uncertainty.Med Phys2014
24439570Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis.Physiotherapy2014
24044911Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort.Urology2014
23899045Exploring gay couples' experience with sexual dysfunction after radical prostatectomy: a qualitative study.J Sex Marital Ther2014
23664820A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.Eur Urol2014
23321581Pathological, oncologic and functional outcomes of radical prostatectomy following active surveillance.J Urol2013
  • 1 - 50 of 250

Recommended Authors

University of Oxford
Career Start Year 2007
Number of shared co-authors 18
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 20
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 4
Northwestern University
Career Start Year 2003
Number of shared co-authors 9
University of British Columbia
Career Start Year 2002
Number of shared co-authors 14
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 5
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 10
OHSU Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 14
The Royal Marsden NHS Foundation Trust
Career Start Year 1996
Number of shared co-authors 4
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 12
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 17
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 6
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 8
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 6
Monash University
Career Start Year 1988
Number of shared co-authors 21
University of California Davis
Career Start Year 1988
Number of shared co-authors 17
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 2
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 7
University of Oxford
Career Start Year 1987
Number of shared co-authors 16
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1987
Number of shared co-authors 18
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 13
University of California san francisco
Career Start Year 1985
Number of shared co-authors 11
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 10
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 21
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 8
Memorial Sloan Kettering Cancer Center
Career Start Year 1981
Number of shared co-authors 12
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 11
Johns Hopkins University
Career Start Year 1977
Number of shared co-authors 8
Memorial Sloan Kettering Cancer Center
Career Start Year 1973
Number of shared co-authors 13
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 14

Collaborators

University of Toronto
Co-authored papers 49
Mount Sinai Hospital, University of Toronto
Co-authored papers 40
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 38
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 31
University Health Network, University of Toronto
Co-authored papers 30
University Health Network
Co-authored papers 27
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 24
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 18
Princess Margaret Hospital, University of Toronto
Co-authored papers 11
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 9
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Mt Sinai Hospital
Co-authored papers 6
University of Western Ontario
Co-authored papers 6
University Health Network
Co-authored papers 6
CHU de Quebec-Universite Laval
Co-authored papers 6
University of Toronto
Co-authored papers 5
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 4
University Health Network
Co-authored papers 4
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 4
Institut du cancer de Montreal
Co-authored papers 3
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Co-authored papers 3
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 3
University of Montreal Health Center
Co-authored papers 3
University of Toronto
Co-authored papers 2
University of Toronto
Co-authored papers 2
Royal Melbourne Hospital
Co-authored papers 2
McGill University Health Centre, McGill University
Co-authored papers 2
University Health Network, University of Toronto
Co-authored papers 2
University of Sao Paulo
Co-authored papers 2
Co-authored papers 2